Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer
Andrew N.J. Tutt, Judy Ellen Garber, Richard D. Gelber, Kelly‐Anne Phillips, Andrea F. Eisen, Oskar T. Johannsson and 14 more
- Rank
- 95 of 3,616
- Percentile
- top 2.7%
- Where
- Annals of Oncology, 2022
- Citations
- 40
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.